Insights on First Imaging Technology to detect Cancer with Imagion Biosystems
November 09, 2021 11:44 AM AEDT
During the first half of 2021, Imagion has continued to make progress in relation to the Phase I Study of its novel MagSense® technology for the detection and staging of HER2 metastatic breast cancer. We speak with Bob Proulx, CEO of Imagion Biosystems about the first imaging technology to use targeted magnetic nanoparticles to tag and detect cancers.
Back To the highs very soon, page-110
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
